November 4, 2010 – GE Healthcare has signed an exclusive collaboration agreement with West Physics Consulting to provide accreditation support. The agreement will support customers seeking accreditation from the American College of Radiology (ACR) for MRI, CT, nuclear medicine and PET systems.

November 3, 2010 – The U.S. Food and Drug Administration (FDA) has approved a new stent delivery system for clinical practice in the United States. The Talent Thoracic Stent Graft with Captivia delivery system, by Medtronic, features a tip capture mechanism for controlled deployment and precise placement of the implantable medical device.

November 3, 2010 – A multicenter CE-mark study has been launched for transapical TAVI system. Hendrik Treede, M.D., performed the first implantations of the system, made by JenaValve, at the Universitäres Herzzentrum Hamburg.

November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure device to warfarin therapy in those with atrial fibrillation. The PREVAIL study will look at Atritech’s Watchman LAA closure device.

Central Baptist Hospital in Lexington, Ky., enrolled the first patient.

November 2, 2010 – Boston Scientific will sell its neurovascular business to Stryker for $1.5 billion in cash. Of that purchase price, $1.4 billion will be paid at closing, and the remaining $100 million will be paid upon commercialization of the Target Detachable Coils. Several manufacturing facilities will also be transferred to Stryker.

November 1, 2010 - After a heart attack victim stops breathing, a process of irreversible brain damage starts to occur within three to four minutes. But a new technique may significantly delay that damage.

Several upgrades are now available on Toshiba’s Viamo ultrasound system, including ApliPure Plus, Tissue Pure Imaging, a new high-frequency, tightly curved transducer and a DICOM structured reporting. Viamo combines the portability of a laptop system with advanced radiology features. The new upgrades enable clinicians to perform advanced exams with greater image definition and clinical accuracy without compromising on patient access. Its unique hinged display allows it to be configured in either a tablet presentation for ease of use or in a laptop mode for in-depth exams.

The Titan 3T is a works-in-progress magnetic resonance (MR) system from Toshiba. The system has several patient-friendly features that are designed to improve the exam experience.

A works-in-progress 160-detector row helical computed tomography (CT) scanning system is being unveiled on the Toshiba Aquilion One and Aquilion Premium during RSNA 2010. Ultra helical scanning can image the entire chest, abdomen and pelvis in less than five seconds, which is 2.5 times faster than standard 64-detector row CT imaging.

Target CTA and the works-in-progress Adaptive Iterative Dose Reduction (AIDR) technology, by Toshiba, lower radiation dose and make CT imaging safer for patients.

Target CTA is a dose cardiac protocol for the Aquilion ONE that is designed for patients with stable heart rates, including pediatrics. When used with the company’s SURECardio Prospective, which can reduce radiation dose by up to 80 percent, Target CTA can lower radiation by another 20 percent.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now